This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow An author's correction has been published
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Schmunis, G. A.
Right arrow Articles by Cruz, J. R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Schmunis, G. A.
Right arrow Articles by Cruz, J. R.

Next Article 

Clinical Microbiology Reviews, January 2005, p. 12-29, Vol. 18, No. 1
0893-8512/05/$08.00+0     doi:10.1128/CMR.18.1.12-29.2005
Copyright © 2005, American Society for Microbiology. All Rights Reserved.

Safety of the Blood Supply in Latin America

Gabriel A. Schmunis* and Jose R. Cruz

Pan American Health Organization, Regional Office of the World Health Organization for the Americas, Washington, D.C.

Appropriate selection of donors, use of sensitive screening tests, and the application of a mandatory quality assurance system are essential to maintain the safety of the blood supply. Laws, decrees, norms, and/or regulations covering most of these aspects of blood transfusion exist in 16 of the 17 countries in Latin America that are the subject of this review. In 17 countries, there is an information system that, although still incomplete (there are no official reports on adverse events and incidents), allows us to establish progress made on the status of the blood supply since 1993. Most advances originated in increased screening coverage for infectious diseases and better quality assurance. However, in 2001 to 2002, tainted blood may have caused infections in 12 of the 17 countries; no country reached the number of donors considered adequate, i.e., 5% of the population, to avoid blood shortages, or decreased significantly the number of blood banks, although larger blood banks are more efficient and take advantage of economies of scale. In those years, paid donors still existed in four countries and replacement donors made up >75% of the blood donors in another eight countries. In addition, countries did not report the number of voluntary donors who were repeat donors, i.e., the healthiest category. In spite of progress made, more improvements are needed.


* Corresponding author. Mailing address: Pan American Health Organization, Regional Office of the World Health Organization for the Americas, 525 23rd St, N.W., Washington, DC 20037. Phone: (202) 974-3272. Fax: (202) 974-3656. E-mail: schmunig{at}paho.org.


Clinical Microbiology Reviews, January 2005, p. 12-29, Vol. 18, No. 1
0893-8512/05/$08.00+0     doi:10.1128/CMR.18.1.12-29.2005
Copyright © 2005, American Society for Microbiology. All Rights Reserved.




This article has been cited by other articles:

  • Schmunis, G. A., Rodriguez, G., Coenen, J., Bellorin, E. G., Gianella, A. (2008). Prevention of Blood-borne Diseases in Bolivia, 1993-2002. Am J Trop Med Hyg 79: 803-808 [Abstract] [Full Text]  
  • Gurtler, R. E, Diotaiuti, L., Kitron, U. (2008). Commentary: Chagas disease: 100 years since discovery and lessons for the future. Int J Epidemiol 37: 698-701 [Full Text]  
  • Martin-Davila, P., Fortun, J., Lopez-Velez, R., Norman, F., Montes de Oca, M., Zamarron, P., Gonzalez, M. I., Moreno, A., Pumarola, T., Garrido, G., Candela, A., Moreno, S. (2008). Transmission of Tropical and Geographically Restricted Infections during Solid-Organ Transplantation. Clin. Microbiol. Rev. 21: 60-96 [Abstract] [Full Text]  
  • Cheng, K. Y., Chang, C.-D., Salbilla, V. A., Kirchhoff, L. V., Leiby, D. A., Schochetman, G., Shah, D. O. (2007). Immunoblot Assay Using Recombinant Antigens as a Supplemental Test To Confirm the Presence of Antibodies to Trypanosoma cruzi. CVI 14: 355-361 [Abstract] [Full Text]  
  • Teixeira, A R L, Nitz, N, Guimaro, M C, Gomes, C, Santos-Buch, C A (2006). Chagas disease. Postgrad. Med. J. 82: 788-798 [Abstract] [Full Text]